Inhibitory capacity of Chloroquine against SARS-COV-2 by effective binding with Angiotensin converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies

{ 'indexed': {'date-parts': [[2024, 3, 11]], 'date-time': '2024-03-11T23:56:35Z', 'timestamp': 1710201395833}, 'reference-count': 32, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2021, 4, 1]], 'date-time': '2021-04-01T00:00:00Z', 'timestamp': 1617235200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 4, 1]], 'date-time': '2021-04-01T00:00:00Z', 'timestamp': 1617235200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-017'}, { 'start': { 'date-parts': [[2021, 4, 1]], 'date-time': '2021-04-01T00:00:00Z', 'timestamp': 1617235200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-037'}, { 'start': { 'date-parts': [[2021, 4, 1]], 'date-time': '2021-04-01T00:00:00Z', 'timestamp': 1617235200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-012'}, { 'start': { 'date-parts': [[2021, 4, 1]], 'date-time': '2021-04-01T00:00:00Z', 'timestamp': 1617235200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-029'}, { 'start': { 'date-parts': [[2021, 4, 1]], 'date-time': '2021-04-01T00:00:00Z', 'timestamp': 1617235200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-004'}], 'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 4]]}, 'DOI': '10.1016/j.molstruc.2021.129891', 'type': 'journal-article', 'created': {'date-parts': [[2021, 1, 8]], 'date-time': '2021-01-08T17:22:13Z', 'timestamp': 1610126533000}, 'page': '129891', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 17, 'title': 'Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin ' 'converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies', 'prefix': '10.1016', 'volume': '1230', 'author': [ {'given': 'Nabajyoti', 'family': 'Baildya', 'sequence': 'first', 'affiliation': []}, {'given': 'Narendra Nath', 'family': 'Ghosh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Asoke P.', 'family': 'Chattopadhyay', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.molstruc.2021.129891_bib0001', 'series-title': 'Research and Development On Therapeutic Agents and Vaccines For COVID-19 ' 'and Related Human Coronavirus Diseases', 'author': 'Liu', 'year': '2020'}, { 'issue': '3', 'key': '10.1016/j.molstruc.2021.129891_bib0002', 'doi-asserted-by': 'crossref', 'first-page': '209', 'DOI': '10.1038/nrmicro775', 'article-title': 'SARS—Beginning to understand a new virus', 'volume': '1', 'author': 'Stadler', 'year': '2003', 'journal-title': 'Nature Reviews Microbiology'}, { 'issue': '9366', 'key': '10.1016/j.molstruc.2021.129891_bib0003', 'doi-asserted-by': 'crossref', 'first-page': '1319', 'DOI': '10.1016/S0140-6736(03)13077-2', 'article-title': 'Coronavirus as a possible cause of severe acute respiratory syndrome', 'volume': '361', 'author': 'Peiris', 'year': '2003', 'journal-title': 'The Lancet'}, { 'issue': '4', 'key': '10.1016/j.molstruc.2021.129891_bib0004', 'first-page': '57', 'article-title': 'A Dynamic Compartmental Mathematical Model Describing The ' 'Transmissibility Of MERS-CoV Virus In Public', 'volume': '51', 'author': 'Tahir', 'year': '2019', 'journal-title': 'Punjab University Journal of Mathematics'}, { 'issue': '9997', 'key': '10.1016/j.molstruc.2021.129891_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '995', 'DOI': '10.1016/S0140-6736(15)60454-8', 'article-title': 'Middle East respiratory syndrome', 'volume': '386', 'author': 'Zumla', 'year': '2015', 'journal-title': 'The Lancet'}, { 'issue': '8', 'key': '10.1016/j.molstruc.2021.129891_bib0006', 'doi-asserted-by': 'crossref', 'first-page': '2991', 'DOI': '10.3390/v6082991', 'article-title': 'The coronavirus nucleocapsid is a multifunctional protein', 'volume': '6', 'author': 'McBride', 'year': '2014', 'journal-title': 'Viruses'}, { 'key': '10.1016/j.molstruc.2021.129891_bib0007', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int. J. Antimicrob. Agents'}, { 'key': '10.1016/j.molstruc.2021.129891_bib0008', 'series-title': 'Remdesivir in Adults With Severe COVID-19: a randomised, Double-Blind', 'author': 'Wang', 'year': '2020'}, { 'issue': '7', 'key': '10.1016/j.molstruc.2021.129891_bib0009', 'doi-asserted-by': 'crossref', 'first-page': '449', 'DOI': '10.2183/pjab.93.027', 'article-title': 'Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase', 'volume': '93', 'author': 'Furuta', 'year': '2017', 'journal-title': 'Proceedings of the Japan Academy, Series B'}, { 'issue': '50', 'key': '10.1016/j.molstruc.2021.129891_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '14408', 'DOI': '10.1073/pnas.1618029113', 'article-title': 'Zika virus cell tropism in the developing human brain and inhibition by ' 'azithromycin', 'volume': '113', 'author': 'Retallack', 'year': '2016', 'journal-title': 'Proceedings of the National Academy of Sciences'}, { 'issue': '1', 'key': '10.1016/j.molstruc.2021.129891_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '6', 'DOI': '10.4172/1948-5964.1000173', 'article-title': 'Azithromycin inhibits the replication of Zika virus', 'volume': '10', 'author': 'Bosseboeuf', 'year': '2018', 'journal-title': 'J Antivirals Antiretrovirals'}, { 'key': '10.1016/j.molstruc.2021.129891_bib0012', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.lfs.2020.117627', 'article-title': 'Virtual screening and repurposing of FDA approved drugs against ' 'COVID-19 main protease', 'author': 'Kandeel', 'year': '2020', 'journal-title': 'Life Sci.'}, { 'issue': '1', 'key': '10.1016/j.molstruc.2021.129891_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '16', 'DOI': '10.1038/s41421-020-0156-0', 'article-title': 'Hydroxychloroquine, a less toxic derivative of chloroquine, is ' 'effective in inhibiting SARS-CoV-2 infection in vitro', 'volume': '6', 'author': 'Liu', 'year': '2020', 'journal-title': 'Cell Discov'}, { 'issue': '10223', 'key': '10.1016/j.molstruc.2021.129891_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in', 'volume': '395', 'author': 'Huang', 'year': '2020', 'journal-title': 'The lancet'}, { 'key': '10.1016/j.molstruc.2021.129891_bib0015', 'doi-asserted-by': 'crossref', 'unstructured': 'Gao J., Tian Z., Yangbreakthrough X., Chloroquine Phosphate has shown ' 'apparent efficacy in treatment of COVID-19 associated pneumonia in ' 'clinical studies, Biosci Trends 14 (1) (2020) 72–73, ' 'doi:10.5582/bst.2020.01047. Epub 2020 Feb 19. PMID: 32074550.', 'DOI': '10.5582/bst.2020.01047'}, { 'issue': '3', 'key': '10.1016/j.molstruc.2021.129891_bib0016', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res.'}, { 'issue': '9', 'key': '10.1016/j.molstruc.2021.129891_bib0017', 'doi-asserted-by': 'crossref', 'first-page': '2845', 'DOI': '10.1021/jm0601856', 'article-title': 'Design and synthesis of hydroxyferroquine derivatives with antimalarial ' 'and antiviral activities', 'volume': '49', 'author': 'Biot', 'year': '2006', 'journal-title': 'J. Med. Chem.'}, { 'issue': '6', 'key': '10.1016/j.molstruc.2021.129891_bib0018', 'doi-asserted-by': 'crossref', 'first-page': '1386', 'DOI': '10.1016/j.ophtha.2016.01.058', 'article-title': 'Recommendations on screening for chloroquine and hydroxychloroquine ' 'retinopathy (2016 revision)', 'volume': '123', 'author': 'Marmor', 'year': '2016', 'journal-title': 'Ophthalmology'}, { 'issue': '13', 'key': '10.1016/j.molstruc.2021.129891_bib0019', 'doi-asserted-by': 'crossref', 'first-page': '1605', 'DOI': '10.1002/jcc.20084', 'article-title': 'UCSF Chimera—A visualization system for exploratory research and ' 'analysis', 'volume': '25', 'author': 'Pettersen', 'year': '2004', 'journal-title': 'J Comput Chem'}, { 'issue': '2', 'key': '10.1016/j.molstruc.2021.129891_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '455', 'DOI': '10.1002/jcc.21334', 'article-title': 'AutoDock Vina: improving the speed and accuracy of docking with a new ' 'scoring function, efficient optimization, and multithreading', 'volume': '31', 'author': 'Trott', 'year': '2010', 'journal-title': 'J Comput Chem'}, { 'issue': '1–3', 'key': '10.1016/j.molstruc.2021.129891_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '43', 'DOI': '10.1016/0010-4655(95)00042-E', 'article-title': 'GROMACS: a message-passing parallel molecular dynamics implementation', 'volume': '91', 'author': 'Berendsen', 'year': '1995', 'journal-title': 'Comput Phys Commun'}, { 'issue': '2', 'key': '10.1016/j.molstruc.2021.129891_bib0022', 'doi-asserted-by': 'crossref', 'first-page': '547', 'DOI': '10.1021/jp410344g', 'article-title': 'CHARMM36 united atom chain model for lipids and surfactants', 'volume': '118', 'author': 'Lee', 'year': '2014', 'journal-title': 'The journal of physical chemistry B'}, { 'issue': '15', 'key': '10.1016/j.molstruc.2021.129891_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '3692', 'DOI': '10.1021/acs.jpcb.6b01316', 'article-title': 'CHARMM TIP3P water model suppresses peptide folding by solvating the ' 'unfolded state', 'volume': '120', 'author': 'Boonstra', 'year': '2016', 'journal-title': 'The journal of physical chemistry B'}, { 'issue': '9', 'key': '10.1016/j.molstruc.2021.129891_bib0024', 'doi-asserted-by': 'crossref', 'first-page': '2031', 'DOI': '10.1002/jcc.21773', 'article-title': 'Optimization of parameters for molecular dynamics simulation using ' 'smooth particle-mesh Ewald in GROMACS 4.5', 'volume': '32', 'author': 'Abraham', 'year': '2011', 'journal-title': 'J Comput Chem'}, { 'key': '10.1016/j.molstruc.2021.129891_bib0025', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.molstruc.2020.128595', 'article-title': 'Inhibitory activity of hydroxychloroquine on COVID-19 main protease: an ' 'insight from MD-simulation studies', 'author': 'Baildya', 'year': '2020', 'journal-title': 'J Mol Struct'}, { 'issue': '12', 'key': '10.1016/j.molstruc.2021.129891_bib0026', 'doi-asserted-by': 'crossref', 'first-page': '322', 'DOI': '10.3390/v8120322', 'article-title': 'Chloroquine, an endocytosis blocking agent, inhibits Zika virus ' 'infection in different cell models', 'volume': '8', 'author': 'Delvecchio', 'year': '2016', 'journal-title': 'Viruses'}, { 'issue': '10', 'key': '10.1016/j.molstruc.2021.129891_bib0027', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0109180', 'article-title': 'Chloroquine is a zinc ionophore', 'volume': '9', 'author': 'Xue', 'year': '2014', 'journal-title': 'PLoS ONE'}, { 'key': '10.1016/j.molstruc.2021.129891_bib0028', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105960', 'article-title': 'Structural and molecular modeling studies reveal a new mechanism of ' 'action of chloroquine and hydroxychloroquine against SARS-CoV-2 ' 'infection', 'author': 'Fantini', 'year': '2020', 'journal-title': 'Int. J. Antimicrob. Agents'}, { 'issue': '11', 'key': '10.1016/j.molstruc.2021.129891_bib0029', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.ppat.1001176', 'article-title': 'Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in ' 'vitro and zinc ionophores block the replication of these viruses in ' 'cell culture', 'volume': '6', 'author': 'Te Velthuis', 'year': '2010', 'journal-title': 'PLoS Pathog.'}, { 'key': '10.1016/j.molstruc.2021.129891_bib0030', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.jmii.2020.04.015', 'article-title': 'ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, ' 'multi-organ failure, and COVID-19 disease outcome', 'author': 'Devaux', 'year': '2020', 'journal-title': 'Journal of Microbiology, Immunology and Infection'}, { 'issue': '11', 'key': '10.1016/j.molstruc.2021.129891_bib0031', 'doi-asserted-by': 'crossref', 'first-page': '722', 'DOI': '10.1016/S1473-3099(03)00806-5', 'article-title': "Effects of chloroquine on viral infections: an old drug against today's " 'diseases', 'volume': '3', 'author': 'Savarino', 'year': '2003', 'journal-title': 'The Lancet infectious diseases'}, { 'key': '10.1016/j.molstruc.2021.129891_bib0032', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.clim.2020.108448', 'article-title': 'COVID-19: immunology and treatment options', 'author': 'Felsenstein', 'year': '2020', 'journal-title': 'Clinical Immunology'}], 'container-title': 'Journal of Molecular Structure', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0022286021000223?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0022286021000223?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 10, 17]], 'date-time': '2023-10-17T07:02:52Z', 'timestamp': 1697526172000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0022286021000223'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 4]]}, 'references-count': 32, 'alternative-id': ['S0022286021000223'], 'URL': 'http://dx.doi.org/10.1016/j.molstruc.2021.129891', 'relation': {}, 'ISSN': ['0022-2860'], 'subject': [], 'container-title-short': 'Journal of Molecular Structure', 'published': {'date-parts': [[2021, 4]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with ' 'angiotensin converting enzyme-2 receptor: An insight from molecular docking and ' 'MD-simulation studies', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Journal of Molecular Structure', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.molstruc.2021.129891', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 Elsevier B.V. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '129891'}